Soluble BTN2A1 as a potential predictive biomarker of immune checkpoint inhibitor efficacy in advanced non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Rochigneux, Philippe
Chretien, Anne Sophie
Rossille, Delphine
Chanez, Brice
Billon, Emilien
Fattori, Stephane
Corre, Romain
Pakradouni, Jihane
Goncalves, Anthony
Fest, Thierry
Madroszyk, Anne
Olive, Daniel
机构：
[1] Inst Paoli Calmettes, CRCM U1068, Marseille, France
[2] CRCM, Marseille, France
[3] Univ Hosp Rennes, Rennes, France
[4] Inst Paoli Calmette, Marseille, France
[5] Rennes Univ Hosp, Rennes, France
[6] Inst Paoli Calmettes, Dept Clin Res & Innovat, Marseille, France
[7] Aix Marseille Univ, Inst Paoli Calmettes, Dept Med Oncol, CRCM,CNRS,INSERM, Marseille, France
[8] Inst Paoli Calmettes CRCM U1068, Marseille, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9561
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Predictive Markers for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Ushio, Ryota
    Murakami, Shuji
    Saito, Haruhiro
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
  • [32] DYNC2H1 mutation as a potential predictive biomarker for immune checkpoint inhibitor efficacy in NSCLC and melanoma
    Yang, Lu
    Feng, Yanlong
    Liu, Xuewen
    Zhang, Qin
    Liu, Yaqin
    Zhang, Xing
    Li, Ping
    Chen, Dongsheng
    INVESTIGATIONAL NEW DRUGS, 2025,
  • [33] Deep learning-based predictive biomarker for immune checkpoint inhibitor response in metastatic non-small cell lung cancer.
    Park, Sehhoon
    Ahn, Chang Ho
    Jung, Geunyoung
    Lee, Sarah
    Paeng, Kyunghyun
    Shin, Jiwon
    Yoo, Inwan
    Jung, Hyun Ae
    Sun, Jong-Mu
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    La Choi, Yoon
    Song, Sang-Yong
    Lee, Se-Hoon
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] Chronic immune checkpoint inhibitor (ICI) pneumonitis in patients (pts) with non-small cell lung cancer (NSCLC).
    Stuart, Jessica
    Ricciuti, Biagio
    Alessi, Joao Victor Machado
    Nishino, Mizuki
    Awad, Mark M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [35] Potential predictive value of change in inflammatory cytokines levels subsequent to initiation of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer
    Lim, Jeong Uk
    Yoon, Hyoung Kyu
    CYTOKINE, 2021, 138
  • [36] Immune checkpoint inhibitor (ICPI) efficacy and resistance detected by comprehensive genomic profiling (CGP) in non-small cell lung cancer (NSCLC)
    Ross, J. S.
    Goldberg, M. E.
    Albacker, L. A.
    Gay, L. M.
    Agarwala, V.
    Elvin, J. A.
    Vergilio, A.
    Suh, J.
    Ramkissoon, S.
    Severson, E.
    Daniel, S.
    Ali, S. M.
    Schrock, A. B.
    Frampton, G. M.
    Fabrizio, D.
    Miller, V. A.
    Singal, G.
    Abernethy, A.
    Stephens, P. J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [37] Imaging of Immune Checkpoint Inhibitor Immunotherapy for Non-Small Cell Lung Cancer
    Shroff, Girish S.
    Strange, Chad D.
    Ahuja, Jitesh
    Altan, Mehmet
    Sheshadri, Ajay
    Unlu, Ebru
    Truong, Mylene T.
    Vlahos, Ioannis
    RADIOGRAPHICS, 2022, 42 (07) : 1956 - 1974
  • [38] Vimentin expression correlates with immune-checkpoint inhibitor efficacy in non-small cell lung cancer
    Nakahama, Kenji
    Izumi, Motohiro
    Yoshimoto, Naoki
    Fukui, Mitsuru
    Sugimoto, Akira
    Nagamine, Hiroaki
    Ogawa, Koichi
    Sawa, Kenji
    Tani, Yoko
    Kaneda, Hiroyasu
    Mitsuoka, Shigeki
    Watanabe, Tetsuya
    Asai, Kazuhisa
    Kawaguchi, Tomoya
    CANCER, 2023, 129 (15) : 2297 - 2307
  • [39] Efficacy of Immune Checkpoint Inhibitor on Non-Small Cell Lung Cancer with Chronic Obstructive Pulmonary Disease
    Zhang, Huohuo
    Li, Weimin
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [40] Efficacy and safety of immune checkpoint inhibitor monotherapy in elderly patients with non-small cell lung cancer
    Chikaishi, Yasuhiro
    Inoue, Masaaki
    Kusanagi, Kasumi
    Honda, Yohei
    Yoshida, Junichi
    Tanaka, Masao
    AGING MEDICINE, 2021, 4 (01) : 42 - 46
12345